(Q39835409)

15 September 2017

1 reference

title

Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome (English)

1 reference

15 September 2017

0 references

1 reference

Llach F

1

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 September 1985

1 reference

15 September 2017

1 reference

15 September 2017

volume

28

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

429-439

1 reference

Treatment of nephrosis with cortisone

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Factor-IX deficiency in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Acquired factor IX deficiency in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Activation of hageman factor in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Urinary Loss of Clotting Factors Due to Hereditary Membranous Glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Deficiency of Hageman factor (factor XII) in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Acquired Factor XII Deficiency in a Patient with Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Deficiency and urinary losses of factor XII in adult nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Factor IX Deficiency in the Nephrotic Syndrome: Studies with Prothrombin Complex Concentrate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Changes of coagulation factors IX, VIII, VII, X, and V in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Nephrotic syndrome. A hypercoagulable state

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Hypercoagulability in the Nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Thrombosis and oral contraceptives: possible predisposition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Fibrinolytic enzyme system and pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Changes in blood coagulation and fibrinolysis during the postoperative period

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Fibrinolytic activity in malignant disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Low vascular fibrinolytic activity in obesity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

FIBRINOLYTIC ACTIVITY IN PLASMA AND URINE IN CHRONIC RENAL DISEASE.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Urinary plasminogen and chronic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Identification and Some Properties of a New Fast-Reacting Plasmin Inhibitor in Human Plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

The primary inhibitor of plasmin in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Fibrinopeptide a immunoreactivity in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Measurement of fibrinopeptide A in human blood

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Relevance of preoperative and postoperative blood tests to postoperative leg-vein thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

A one-year follow-up study of plasma fibrinopeptide A and beta-thromboglobulin after deep vein thrombosis and pulmonary embolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Fibrinopeptide a (FPA) in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Cryofibrinogenaemia in women using oral contraceptives

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

The laboratory diagnosis of venous thromboembolic disease by measurement of fibrinogen-fibrin degradation products and fibrin monomer

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Association between oral contraceptive use and thromboembolism: A new approach to its investigation based on plasma fibrinogen chromatography

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Soluble fibrin complexes in coronary disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Serum and Urinary Fibrin/Fibrinogen Degradation Products in Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Chronic renal vein thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Urinary fibrin-fibrinogen degradation products in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Actions and Interactions of Antithrombin and Heparin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Progressive inactivation of purified factor VII by heparin and antithrombin III

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Inherited Antithrombin Deficiency Causing Thrombophilia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Unilateral renal vein thrombosis and nephrotic syndrome. Report of a case with protein selectivity and antithrombin III clearance studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Comprehensive study of haemostasis in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Anticoagulant properties of bovine plasma protein C following activation by thrombin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Proteolytic activation of protein C from bovine plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Deficiency of protein C in congenital thrombotic disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Recurrent venous thromboembolism in patients with a partial deficiency of protein S.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

New rapid method for diagnosis of deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Platelet function in hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Platelet hypersensitivity induced by cholesterol incorporation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

On the inhibitory effect of albumin on platelet aggregation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Platelet hyperaggregability and the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

β-thromboglobulin levels in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Post-thrombotic Inferior Vena Caval Obstruction: A Review of 24 Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Bilateral renal-vein thrombosis and the nephrotic syndrome in adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Renal vein thrombosis in membranous glomerulonephropathy: incidence and association

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Renal vein thrombosis and nephrotic syndrome. A prospective study of 36 adult patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

The clinical spectrum of renal vein thrombosis: acute and chronic

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Letter: Renal vein thrombosis in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Study of proteins and fibrinolysis in patients with glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Ultrasonic demonstration of renal vein thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

The detection of inferior vena caval thrombosis with computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Bilateral renal vein thrombosis. Clinical and electron microscopic studies of a case with complete recovery after anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Nephrotic syndrome, renal vein thrombosis and renal failure. Report of case with recovery of renal function, loss of proteinuria and dissolution of thrombus after anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Anticoagulation in renal vein thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Urokinase therapy of subclavian-axillary vein thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Thrombosis of Axillary and Subclavian Veins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Vascular Complications in Nephrotic Syndrome: Relationship to Steroid Therapy and Accelerated Thromboplastin Generation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1985.149

7 January 2021

Identifiers

DOI

10.1038/KI.1985.149

1 reference

Dimensions Publication ID

15 September 2017

1036288065

0 references

1 reference